BPS 2017

EVERY ANALYST MUST KNOW HPTLC, TO CHOOSE THE MOST ADAPTED METHOD FOR ANY SAMPLE NEED, OR JUST TO SQUARE THE CIRCLE.

Pierre Bernard-Savary

President, Intl Symposium for HPTLC / Club de CCM / Chromacim

ABSTRACT

Sometimes life is not easy with two choices only, and neither of them fit to your expectations or needs…
In chromatography, between HPLC and GC, there is a Third Way : HPTLC.
HPTLC stands for High Performance Thin Layer Chromatography and is nearly unknown in it’s current version by American Analysts. Only Botanicals specialists use the “Fingerprint” version of this technique which isn’t neither a real separation nor very sensitive or quantitative version of HPTLC. The “old TLC” is now more than 75 years old, and it is time to replace it by a relatively newer method. Until now, HPTLC grew in the shadow of UHPLC.
But HPTLC, which is a liquid chromatography too, is easier to couple with any other method, especially for detection [1]. This detection feature is especially very interesting for molecules with detections problem as non UV absorbance or fluorescence. It may also help better quantification through a high selectivity. This leads to a paradoxical much higher sensitivity to impurities, compared to UPLC or GC in many cases
This wide detection range enables to get both identification and quantification. High sample amounts may be also evaporated during spray-on sample application which helps to get a high sensitivity.
The focus will be given on the current features of the method, and on when it might be the method of choice.
Recent improvement of MS detection on plates increases the interest of HPTLC. And the detection of activity directly on the plate ( EDA for effect directed analysis ) is also a very powerful tool, including for example the detection of an anti fungal or of an antibiotic against Staph. Aureus or of an unknown endocrine disruptive, down to the fg level, directly on the plate.
These capabilities of HPTLC are finally due to the fact that after separation, the complete sample does not go to the waste, but remains accessible on the plate, for further evaluation.
The compatibility with biological matrix has very few limitations on a plate, especially regarding single use of the plate separation medium.
There is less risk on the plate to miss any sample compound, as all sample is accessible, and the range type of detection is much wider, as including chemical staining and “bio-detection”.
It is faster due to parallel separations with up to more than 50 analyses on a single HPTLC 20×10 plate, and due to instant start as neither prior rinsing nor column equilibrium is needed on plates. This analytical speed to find a new compound having the expected properties helps the speed of the drug discovery.
As time is money, and as HPTLC requires a very little solvent consumption only, it is a cheap method.
As any method, HPTLC has of course limitations, which are actually the miss of knowledge about it.
The International Symposium for HPTLC which took place in Berlin, Germany, in July 2018, was showing a shortcut of most of the best current research in this field. (www.hptlc.com).
This kind of meeting is a way to compensate this weakness.
Due to it’s success we decided in addition to the three-years international meeting in Europe since 2003, to start a series in Asia and in America. Next meeting will therefore take place in Bangkok end of November 2018, and we are also planning a meeting in 2019, why not in Boulder. Next International meeting in Eurpe will be in Lubijana in July 2020. www.hptlc.com.

Literature: [1] G. Morlock, W. Schwack, JCA 1217 (2010) 6600-6609.

BIO

Pierre Bernard-Savary
French, 58 y.o.3 children ( incl elder daughter Julia in college Astrophysics in CU Boulder since 2015), widower since June this year.
3rd participation to BPS
Club de CCM ( TLC Club ) founder in 1998, and chairman (see clubdeccm.com only in french)
International Symposium for HPTLC elected chairman in 2001 (see hptlc.com)
Chromatographer HPLC since 1984, TLC&HPTLC specialist since 1992,(1st product manager in France by Merck Darmstadt cny until 2001).
Chromacim SAS (company) founder in 2002 (7 persons 2.5 M$ to ) and chairman
Member of various committees including AFSEP (French national association of separation sciences)
co-author of the lecture is Prof G.Morlock see https://www.uni-giessen.de/fbz/fb09/institute/ernaehrungswissenschaft/prof/lmw/ag/arbeitsgruppe/gertrud-morlock/view

Information for BPS Presenters

The Boulder Peptide Foundation was established to further the science and knowledge of peptide technology to develop novel therapeutics, biomaterials, medical diagnostics and other beneficial uses for mankind. As part of this goal we run several programs to support career advancement, seminars and educational events. Join us on our mission to expand the applications of peptide science.

Information for BPS Presenters

The purpose of the Boulder Peptide Symposium is to encourage sharing of information related to peptide therapeutic development with an emphasis on the technical, scientific and regulatory aspects of the pharmaceutical development. Presentations that demonstrate original thinking or share experiences from case studies in product development shall receive priority over others.

The Boulder Peptide Symposium offers multiple opportunities for participants to present.

Oral Presentations in Scientific Sessions

The session topics for Scientific Program are Peptides in the Clinic, Drug Delivery, Chemistry of Complex Peptides, Spotlight on Discovery, and Peptide Showcase. Abstracts may be submitted via the Apply to Present page on the website. Submissions will be reviewed by the Scientific Advisory Board on a monthly basis and the speaker will be notified of a decision.

Presentation length: Format is 25-30 minutes slide presentation with 5-10 minutes for Q&A, with the exception of Peptide Showcase talks which are 10 minute slide presentations with 5 minutes for Q&A. Please confirm with your session chair to confirm the exact presentation length.

Invited Speakers: Speakers are requested to supply their presentation details 30 days after receiving an invitation to present.

Program Book Deadline: Final abstract and title must be provided no later than September 1st. No changes to the program are possible after this date.

Presentation Format: Oral presenters please provide your presentation slides to the A/V table on the day of your presentation.

Lodging: All speakers are requested to reserve their own room. Discount rates at the conference hotel are available until August 16th.

Registration: All speakers, excluding sponsored presentation speakers, receive a complimentary registration upon approval of the abstract.

Peptide Showcase Description

The Peptide Showcase is an opportunity for an individual or company to “showcase” new ideas, technology and pipeline assets. Priority shall be given to presentations from biotech and startup companies. Service providers and vendors are not eligible. Speakers in the session receive a complimentary event registration.

Posters

Posters can be presented on any topic relevant to peptides including original research, innovative products and technologies.

Eligibility- Any attendee (from academia, industry, biotech or vendor/sponsor) can present a poster. The presentation must contain original scientific thinking. To submit a poster go to the Submit a Poster link from the meeting menu. All submissions are reviewed on a rolling basis and will be notified of approval. September 1st is the last day to submit a poster abstract. Approved posters are published on the BPF website.

A 30 ” x 40″ board shall be provided with thumb tacks. Board will be on an easel and can be rotated for either landscape or portrait formats. Once you apply for a poster, you will get email confirmation that your poster was accepted. The poster session and number assignments will be emailed one week before the Symposium.

Poster boards shall be available for display from 8am to 8pm the day of your assigned poster session. See the program agenda for the poster session schedule.

Public Release

Every presentation at the Boulder Peptide Symposium is automatically recorded. Speakers are required to give consent for sharing of the presentation video with the peptide community.

Refund Policy - Terms and Conditions - Privacy Policy